Effect of Dadimadi Churna in managing productive cough (Kaphaj Kasa)

Clinical evaluation of Dadimadi Churna in Kaphaja Kasa in children - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/07/113606

Enrollment

Registered

2026-07-07

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J209- Acute bronchitis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children between the ages of 5-10 years, presenting with the classical feature of Kaphaja Kasa 2.Cough with chronicity less than 14 days. 3.Both male and female patients, irrespective of cast, religion, or economic status

Exclusion criteria

Exclusion criteria: 1.Children below 5 years and above 10 years. 2.Patient presenting with symptoms other than Kaphaja Kasa. 3.Patients with K/C/O Allergic bronchitis, Chronic bronchitis, Pneumonia, Asthma, Pertussis, Emphysema, COVID-19. 4.Cough with chronicity more than 14 days. 5.Patients with chronic or debilitating systemic illness like HIV, TB.

Design outcomes

Primary

Measure	Time frame
Clinical evaluation of Dadimadi Churna in Kaphaj Kasa Subjectively all signs and symptoms are given with grading depending upon their severityTimepoint: 4 days	—

Secondary

Measure	Time frame
Clinical evaluation of efficacy of Dadimadi Churna in Kaphaj Kasa with Subjective assessment of all clinical signs & symptoms are given with grading depending upon their severityTimepoint: 4 days	—

Countries

India

Contacts

Public ContactNishi Pandey

Rishikul Campus, Haridwar

keerti.vrm@gmail.com9997777833

Outcome results